Clinical Trials Logo

Hemorrhagic Cystitis clinical trials

View clinical trials related to Hemorrhagic Cystitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03129126 Completed - Clinical trials for Hemorrhagic Cystitis

The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of three doses of LP-10 (intravesical tacrolimus). Twelve subjects meeting the inclusion and exclusion criteria will be enrolled and treated in a prospective and multi-center trial with LP-10. The proposed trial will recruit 12 subjects in a dose-escalation trial where 4 subjects will be allocated into each one of three groups.

NCT ID: NCT02172963 Completed - Clinical trials for Hemorrhagic Cystitis

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

Start date: November 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy using placenta derived decidual stromal cell therapy for hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. It is hypothesized that the decidual stromal cell therapy is safe to infuse and that they have a positive clinical effect.